Kronox Lab Sciences: The Exchange has received revised Disclosure
Kronox Lab Sciences (KRONOX) filed a disclosure titled "The Exchange has received revised Disclosure". The company is valued at about ₹717 crore.
What happened
Kronox Lab Sciences (KRONOX) filed a disclosure with the exchanges on 11 November 2026 at 12:03 PM titled "The Exchange has received revised Disclosure".
Company snapshot
Kronox Lab Sciences is a micro-cap company, with a market value of about ₹717 crore.
The stock last traded at ₹193.3, against a 52-week range of ₹96–₹227.7 (15.1% below the high).
Before this filing the shares had moved −3.5% over the month and +18.3% over three months. Average daily turnover over the last 20 sessions was about ₹0.88 crore.
Promoters held 64.26% at the end of Q2 FY27, down 9.95% points from the previous quarter. Foreign institutions owned 0.10% and domestic institutions 2.54%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q2 FY26 | 26 | 6.7 | 1.82 |
| Q3 FY26 | 25 | 6.6 | 1.79 |
| Q4 FY26 | 26 | 8 | 2.18 |
| Q1 FY27 | 28 | 7.3 | 2 |
| Q2 FY27 | 55 | 13.7 | 3.7 |
What history shows
BCEIE's records show 1 previous pledge filing from the company since May 2026.
Market-wide, 603 pledge filings with an impact score of 50 or more saw an average next-day move of +0.7%, with 52% rising.
Past reactions describe what happened before; they are not a forecast.
In the news
Recent coverage elsewhere (links open the original publisher):
- Kronox Lab Sciences Q1 net profit up 16% YoY to ₹7.3 crore
- Kronox Lab Sciences Limited Open Offer Seeks 25.79% at ₹157.27
- Kronox Lab Sciences open offer by Indo Borax opens Nov 6 at ₹157.27
- Kronox Lab Sciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2026
- Kronox Lab Sciences Limited (KRONOX.NS) Seasonal returns chart
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.